120 related articles for article (PubMed ID: 33675611)
21. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of miR-125b-5p and Its Prospective Molecular Mechanism in Lung Squamous Cell Carcinoma.
Huang SP; Jiang YF; Yang LJ; Yang J; Liang MT; Zhou HF; Luo J; Yang DP; Mo WJ; Chen G; Shi L; Gan TQ
Cancer Biother Radiopharm; 2022 Mar; 37(2):125-140. PubMed ID: 32614608
[No Abstract] [Full Text] [Related]
23. circCNN2 Accelerates Cell Proliferation and Invasion in Lung Squamous Cell Carcinoma via Regulating miR-184/E2F1 and Activating MAPK Signaling Pathway.
Hu S; Cao P; Kong K; Han P; Yue J; Deng Y; Li F; Zhao B
Dis Markers; 2022; 2022():6329097. PubMed ID: 36016851
[TBL] [Abstract][Full Text] [Related]
24. LncRNA NNT-AS1 promotes lung squamous cell carcinoma progression by regulating the miR-22/FOXM1 axis.
Ma J; Qi G; Li L
Cell Mol Biol Lett; 2020; 25():34. PubMed ID: 32514270
[TBL] [Abstract][Full Text] [Related]
25. Implication of downregulation and prospective pathway signaling of microRNA-375 in lung squamous cell carcinoma.
Chen WJ; Gan TQ; Qin H; Huang SN; Yang LH; Fang YY; Li ZY; Pan LJ; Chen G
Pathol Res Pract; 2017 Apr; 213(4):364-372. PubMed ID: 28214218
[TBL] [Abstract][Full Text] [Related]
26. MicroRNAs associated with lung squamous cell carcinoma: New prognostic biomarkers and therapeutic targets.
Qi L; Gao C; Feng F; Zhang T; Yao Y; Wang X; Liu C; Li J; Li J; Sun C
J Cell Biochem; 2019 Nov; 120(11):18956-18966. PubMed ID: 31241205
[TBL] [Abstract][Full Text] [Related]
27. Ginsenoside Rh2 attenuates the progression of non-small cell lung cancer by sponging miR-28-5p/STK4 axis and inactivating Wnt/β-catenin signaling.
Ma J; Zhao D; Yu D; Song W; Yang X; Yin H
Cancer Med; 2023 Jun; 12(11):12653-12667. PubMed ID: 37081781
[TBL] [Abstract][Full Text] [Related]
28. Expression of miR-486-5p and its significance in lung squamous cell carcinoma.
Yang S; Sui J; Liu T; Wu W; Xu S; Yin L; Pu Y; Zhang X; Zhang Y; Shen B; Liang G
J Cell Biochem; 2019 Aug; 120(8):13912-13923. PubMed ID: 30963622
[TBL] [Abstract][Full Text] [Related]
29. MiR-210-3p targets CELF2 to facilitate progression of lung squamous carcinoma through PI3K/AKT pathway.
Zhang Q; Wang Y
Med Oncol; 2022 Aug; 39(11):161. PubMed ID: 35972577
[TBL] [Abstract][Full Text] [Related]
30. HTR2B as a novel biomarker of chronic obstructive pulmonary disease with lung squamous cell carcinoma.
Li Y; Wang Y; Wu R; Li P; Cheng Z
Sci Rep; 2024 Jun; 14(1):13206. PubMed ID: 38851806
[TBL] [Abstract][Full Text] [Related]
31. CircTIMELESS regulates the proliferation and invasion of lung squamous cell carcinoma cells via the miR-136-5p/ROCK1 axis.
Zhang W; Shi J; Cheng C; Wang H
J Cell Physiol; 2020 Sep; 235(9):5962-5971. PubMed ID: 31960961
[TBL] [Abstract][Full Text] [Related]
32. MiR-497-5p down-regulates CDCA4 to restrains lung squamous cell carcinoma progression.
Hu J; Xiang X; Guan W; Lou W; He J; Chen J; Fu Y; Lou G
J Cardiothorac Surg; 2021 Nov; 16(1):330. PubMed ID: 34772428
[TBL] [Abstract][Full Text] [Related]
33. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY
J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832
[TBL] [Abstract][Full Text] [Related]
34. Identification of a dysregulated ceRNA network modulated by copy number variation-driven lncRNAs in lung squamous cell carcinoma.
Ding J; Huang M; Huang B; Peng X; Wu G; Peng C; Zhang H; Mao C; Wu X
Environ Mol Mutagen; 2022 Aug; 63(7):351-361. PubMed ID: 36161731
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of T-cell cytotoxic marker IL18R1 promotes cancer proliferation and migration and is associated with dismal prognosis and immunity in lung squamous cell carcinoma.
Guo Q; Wu CY; Jiang N; Tong S; Wan JH; Xiao XY; Mei PY; Liu HS; Wang SH
Front Immunol; 2022; 13():986447. PubMed ID: 36544782
[TBL] [Abstract][Full Text] [Related]
36. MiRNA expression profiling in adenocarcinoma and squamous cell lung carcinoma reveals both common and specific deregulated microRNAs.
Petkova V; Marinova D; Kyurkchiyan S; Stancheva G; Mekov E; Kachakova-Yordanova D; Slavova Y; Kostadinov D; Mitev V; Kaneva R
Medicine (Baltimore); 2022 Aug; 101(33):e30027. PubMed ID: 35984198
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-183 Acts as a Tumor Suppressor in Human Non-Small Cell Lung Cancer by Down-Regulating MTA1.
Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
Cell Physiol Biochem; 2018; 46(1):93-106. PubMed ID: 29587281
[TBL] [Abstract][Full Text] [Related]
38. Calcium-activated nucleotidase 1 silencing inhibits proliferation, migration, and invasion in human clear cell renal cell carcinoma.
Liu X; Yang Z; Luo X; Luo J; Fu W; Fang Z; Xia D; Li L; Xu J
J Cell Physiol; 2019 Dec; 234(12):22635-22647. PubMed ID: 31102300
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G
Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858
[TBL] [Abstract][Full Text] [Related]
40. Role of downregulated ADARB1 in lung squamous cell carcinoma.
Wang X; Ren X; Liu W; Chen X; Wei J; Gong Z; Yan Y; Xu Z
Mol Med Rep; 2020 Mar; 21(3):1517-1526. PubMed ID: 32016472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
